Genzyme Corp. will have to submit to inspections of one of its plants by the...
The Food and Drug Administration has approved a drug for treating a condition that causes...
A mid-stage clinical trial of a drug for muscular dystrophy got mixed results, developers Genzyme...
The Food and Drug Administration has approved a new drug for treating a rare genetic...
GlaxoSmithKline has identified more than 5,500 rare diseases it could potentially target as part of...
Bayer Schering Pharma will halt a mid-stage clinical trial of an investigational treatment for hemophilia,...
Prospective college students living with bleeding disorders have a chance to receive a scholarship from...
GlaxoSmithKline has obtained an exclusive license to develop and commercialize an investigational treatment for such...